Meganuska

Indica

Also known as: Meganuska 99, Meganuska 99 F2

What is the Meganuska strain?

Meganuska is a indica cannabis strain with up to 24.0% THC, known for its relaxed effects and earthy and fruity flavor profile.

Meganuska is a classic indica-dominant cannabis strain with origins tracing back to the late 1990s. The strain was developed by breeder Scott Blakey, also known as Shantibaba, during his time with the Mr. Nice Seedbank. Meganuska was created by crossing two legendary landrace strains: G13 and Hash Plant. The name 'Meganuska' is derived from the combination of 'Mega' (referring to its potent effects) and 'Anuska' (a tribute to a friend of the breeder). This strain gained popularity in the early 2000s among European cannabis enthusiasts for its powerful sedative properties and distinctive aroma profile.

The plant typically displays classic indica characteristics with broad, dark green leaves and dense, resinous buds that often develop purple hues when exposed to cooler temperatures during flowering. The buds are covered in a thick layer of trichomes, giving them a frosty appearance. Meganuska plants tend to be relatively short and bushy, making them suitable for indoor cultivation where height is limited. The flowering period is moderately long, typically ranging from 8 to 10 weeks, with outdoor harvests occurring in late September to early October in the Northern Hemisphere.

Meganuska is particularly noted for its complex terpene profile that combines earthy, hash-like aromas with subtle fruity undertones. The strain has maintained a dedicated following among indica enthusiasts despite not achieving the widespread commercial popularity of some other classic strains. Its genetic stability and consistent effects have made it a favorite among growers seeking reliable, high-quality indica genetics. Some breeders have used Meganuska in hybridization projects to enhance the potency and resin production of other strains.

What are the effects of Meganuska?

What are the medical benefits of Meganuska?

  • Users report relief from chronic pain
  • May help with insomnia and sleep disorders
  • Often used for muscle spasms and tension
  • Some users find it helpful for stress and anxiety reduction
  • May provide appetite stimulation

This is not medical advice. Consult a healthcare professional.

What are the side effects of Meganuska?

How do you grow Meganuska?

Meganuska is considered a moderate-difficulty strain to cultivate. The plants typically flower in 8-10 weeks indoors, with outdoor harvests ready in late September to early October in northern climates. Indoor yields are moderate to high, averaging 400-500 grams per square meter, while outdoor plants can produce 500-600 grams per plant under optimal conditions. The strain prefers a controlled indoor environment but can also be grown outdoors in temperate climates with low humidity. Plants remain relatively short, usually reaching 80-120 cm indoors and 120-180 cm outdoors. Special considerations include maintaining low humidity during flowering to prevent mold (due to dense buds) and providing adequate support for heavy colas. The strain responds well to training techniques like topping and low-stress training to maximize yields.

How should you use Meganuska?

Meganuska is a indica strain with 24.0% THC, which is moderate potency. As an indica, it is best suited for evening or nighttime use.

Beginners

Start with 1-2 small inhalations or 2.5-5mg if using edibles. Wait 15 minutes before taking more. This strain is potent — start very low.

Regular Users

A standard session of 3-5 inhalations or 5-15mg edible dose. Effects typically onset within 5-15 minutes when inhaled, 30-90 minutes for edibles.

Experienced Users

Adjust to personal tolerance. Moderate doses should provide a satisfying experience.

Start low and go slow. This is not medical advice — consult a healthcare professional before using cannabis.

What is the genetic lineage of Meganuska?

What are Meganuska's parent strains?

Frequently Asked Questions

How does Meganuska make you feel?

Meganuska is a indica strain that primarily produces relaxed effects, followed by sleepy. Users report the dominant effect at 90% intensity. With 24.0% THC, this strain is moderately strong and suitable for regular consumers.

Is Meganuska good for medical use?

Meganuska has been reported by users for users report relief from chronic pain, may help with insomnia and sleep disorders, often used for muscle spasms and tension, some users find it helpful for stress and anxiety reduction, may provide appetite stimulation. As an indica strain, it may be particularly suited for evening or nighttime use.

This is not medical advice. Consult a healthcare professional.

Are there side effects with Meganuska?

Some users have reported dry mouth, dry eyes, dizziness, dry mouth (common), dry eyes (common), dizziness or lightheadedness in some users, may cause couch-lock or sedation, possible paranoia in sensitive individuals or high doses when using Meganuska. Starting with a low dose and staying hydrated can help minimize these effects.

What does Meganuska taste and smell like?

Meganuska features a flavor profile of earthy, fruity, hash, spicy, woody. The dominant terpenes are Myrcene and Caryophyllene, which contribute to its distinctive aroma.

What do users say about Meganuska?

No reviews yet. Be the first to review Meganuska!

What does the research say about Meganuska?

Meganuska is a indica cannabis strain containing up to 24.0% THC, with a terpene profile dominated by Myrcene and Caryophyllene. Below are authoritative resources for understanding the compounds in this strain.

What strains are similar to Meganuska?